Jean-Christophe Mifsud, Chief Executive Officer of Alpha MOS S.A. (ENXTPA:ALM) agreed to acquire 10% stake in Alpha MOS S.A. (ENXTPA:ALM) from Diagnostic Medical Systems S.A. (ENXTPA:DGM) for 0.9 million on November 16, 2015. Jean-Christophe Mifsud acquired 2.3 million shares of Alpha MOS S.A. for 0.4 per share.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 EUR | +6.38% | +12.18% | -16.07% |
Apr. 25 | Alpha MOS: share price advances on 'positive' outlook | CF |
Apr. 25 | Alpha MOS S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.07% | 18.2M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+1.94% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- ALNEO Stock
- News Alpha MOS
- Jean-Christophe Mifsud, Chief Executive Officer of Alpha MOS S.A. agreed to acquire 10% stake in Alpha MOS S.A. for €0.9 million.